Takarabe Masataka, Shigemizu Daichi, Kotera Masaaki, Goto Susumu, Kanehisa Minoru
Bioinformatics Center, Institute for Chemical Research, Kyoto University, Uji, Kyoto 611-0011, Japan.
Genome Inform. 2010 Jan;22:167-75.
Drug interactions which may cause harmful events are important for our health and new drag development. In the previous work, we extracted the drug interaction data from Japanese drug package inserts and generated the drug interaction network. The network contains a large number of drugs densely connected to each other, where drug targets and drug-metabolizing enzymes were shared in the drug interactions. In this study, we further analyzed the obtained drug interaction network by merging drugs into drug categories based on the Anatomical Therapeutic Chemical (ATC) classification. The merged data of drug interactions indicated drug properties that are related to drug interaction mechanisms or symptoms. We investigated the relationships between the drug groups and drug interaction mechanisms or symptoms.
可能导致有害事件的药物相互作用对我们的健康和新药研发很重要。在之前的工作中,我们从日本药品说明书中提取了药物相互作用数据,并生成了药物相互作用网络。该网络包含大量彼此紧密相连的药物,其中药物靶点和药物代谢酶在药物相互作用中是共享的。在本研究中,我们基于解剖学治疗学化学(ATC)分类将药物合并为药物类别,进一步分析了获得的药物相互作用网络。药物相互作用的合并数据表明了与药物相互作用机制或症状相关的药物特性。我们研究了药物组与药物相互作用机制或症状之间的关系。